TNB Financial cut its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 43.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,185 shares of the healthcare conglomerate’s stock after selling 900 shares during the quarter. TNB Financial’s holdings in UnitedHealth Group were worth $261,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of UNH. Exane Derivatives raised its stake in shares of UnitedHealth Group by 15,333.3% in the fourth quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after purchasing an additional 460 shares in the last quarter. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at $114,000. Acrospire Investment Management LLC raised its stake in shares of UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares in the last quarter. Baystate Wealth Management LLC raised its stake in shares of UnitedHealth Group by 64.9% in the fourth quarter. Baystate Wealth Management LLC now owns 762 shares of the healthcare conglomerate’s stock valued at $186,000 after purchasing an additional 300 shares in the last quarter. Finally, Legacy Advisors LLC raised its stake in shares of UnitedHealth Group by 546.0% in the fourth quarter. Legacy Advisors LLC now owns 801 shares of the healthcare conglomerate’s stock valued at $176,000 after purchasing an additional 677 shares in the last quarter. Institutional investors own 86.78% of the company’s stock.
Shares of UnitedHealth Group Inc (NYSE:UNH) opened at $225.05 on Tuesday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market capitalization of $220,491.67, a price-to-earnings ratio of 21.01, a PEG ratio of 1.33 and a beta of 0.74. UnitedHealth Group Inc has a 1-year low of $162.74 and a 1-year high of $250.79.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.11 earnings per share. research analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend is Thursday, March 8th. UnitedHealth Group’s payout ratio is presently 28.01%.
A number of brokerages recently commented on UNH. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a research note on Saturday, January 20th. Argus upped their target price on UnitedHealth Group to $270.00 and gave the company a “buy” rating in a research note on Thursday, January 18th. Deutsche Bank upped their target price on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Citigroup upped their target price on UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Finally, Piper Jaffray Companies restated a “buy” rating and issued a $259.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Two equities research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $245.14.
In other news, Director William C. Ballard, Jr. sold 10,000 shares of the stock in a transaction on Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the sale, the director now owns 76,637 shares in the company, valued at $18,881,824.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kenneth Irwin Shine sold 198 shares of the stock in a transaction on Friday, January 19th. The stock was sold at an average price of $242.55, for a total value of $48,024.90. Following the sale, the director now owns 1,790,567 shares in the company, valued at approximately $434,302,025.85. The disclosure for this sale can be found here. Insiders have sold 67,015 shares of company stock worth $15,635,599 in the last 90 days. Company insiders own 0.89% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Inc (UNH) Shares Sold by TNB Financial” was originally reported by Stock Observer and is the sole property of of Stock Observer. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.thestockobserver.com/2018/03/20/unitedhealth-group-inc-unh-shares-sold-by-tnb-financial.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.